These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7533450)

  • 1. [Hormonal therapy of benign prostatic hyperplasia].
    Horninger W; Bartsch G
    Urologe A; 1995 Jan; 34(1):9-15. PubMed ID: 7533450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications of antiandrogens in benign hyperplasia of the prostate].
    Benassayag E
    J Urol (Paris); 1995; 101(2):109-10. PubMed ID: 8522854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-surgical treatment of benign prostatic hypertrophy. Current status of the problem].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 1992; 147(1-2):125-35; discussion 135-7. PubMed ID: 1384903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia: drug and nondrug therapies.
    Bruskewitz RC
    Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA
    East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of benign prostatic hyperplasia].
    Hansen J; Hald T
    Ugeskr Laeger; 1993 Dec; 155(50):4058-64. PubMed ID: 7505965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical management of prostatic diseases.
    Schlegel PN
    Adv Intern Med; 1994; 39():569-601. PubMed ID: 7511322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
    Granados EA
    Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Stockamp K
    Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia.
    McConnell JD
    Urol Clin North Am; 1990 Aug; 17(3):661-70. PubMed ID: 1695786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
    Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Androgen deprivation in benign prostatic hypertrophy].
    Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G
    J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of benign prostatic hyperplasia. Alternatives to standard therapy.
    Silverstein JI; Badlani GH; Smith AD
    Clin Geriatr Med; 1990 Feb; 6(1):69-84. PubMed ID: 1689206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options in benign prostatic hypertrophy.
    Stone NN
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of benign prostatic hyperplasia, current options and future perspectives.
    Hansen BJ
    Scand J Urol Nephrol Suppl; 1996; 180():1-55. PubMed ID: 8936639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia. The Saudi perspective in the year 2000.
    Mosli HA; Atwa MA; Mahassini SH
    Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.